Lilly says with new data, it will seek another approval for Cyramza next year

Eric Palmer

Eli has harbored big hopes for its newly approved cancer fighter . It expects it to get a string approvals, and with new in hand, it said it will go to the FDA with an application for colon cancer in the first half of .

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS